First-in-Human, Dose Escalation Trial of AXV-101 in BBS1-Related Retinal Degeneration
Clinical trial NCT07269665 · RECRUITING
Trial details
- NCT number
- NCT07269665
- Sponsor
- Axovia Therapeutics
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-26
- Primary completion
- 2027-02-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.